Cargando…
Ablation of ventricular tachycardia in 2021
Nowadays, ablation of ventricular tachycardia (VT) in structural heart disease is an increasingly used procedure. In fact, it is the most effective strategy in controlling arrhythmic burden in VT patients. The ablative approaches are the result of the last 10 years of technological advances (Cathete...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876297/ https://www.ncbi.nlm.nih.gov/pubmed/35233211 http://dx.doi.org/10.1093/eurheartj/suab082 |
| _version_ | 1784658133521530880 |
|---|---|
| author | Bianchi, Stefano Cauti, Filippo Maria |
| author_facet | Bianchi, Stefano Cauti, Filippo Maria |
| author_sort | Bianchi, Stefano |
| collection | PubMed |
| description | Nowadays, ablation of ventricular tachycardia (VT) in structural heart disease is an increasingly used procedure. In fact, it is the most effective strategy in controlling arrhythmic burden in VT patients. The ablative approaches are the result of the last 10 years of technological advances (Catheters, 3D mapping systems) and the constant study of the pathophysiological mechanisms underlying arrhythmic circuits. This presentation seeks to revisit the state of the art in the ablative treatment of VT. |
| format | Online Article Text |
| id | pubmed-8876297 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88762972022-02-28 Ablation of ventricular tachycardia in 2021 Bianchi, Stefano Cauti, Filippo Maria Eur Heart J Suppl Articles Nowadays, ablation of ventricular tachycardia (VT) in structural heart disease is an increasingly used procedure. In fact, it is the most effective strategy in controlling arrhythmic burden in VT patients. The ablative approaches are the result of the last 10 years of technological advances (Catheters, 3D mapping systems) and the constant study of the pathophysiological mechanisms underlying arrhythmic circuits. This presentation seeks to revisit the state of the art in the ablative treatment of VT. Oxford University Press 2021-10-08 /pmc/articles/PMC8876297/ /pubmed/35233211 http://dx.doi.org/10.1093/eurheartj/suab082 Text en Published on behalf of the European Society of Cardiology. © The Author(s) 2021. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Articles Bianchi, Stefano Cauti, Filippo Maria Ablation of ventricular tachycardia in 2021 |
| title | Ablation of ventricular tachycardia in 2021 |
| title_full | Ablation of ventricular tachycardia in 2021 |
| title_fullStr | Ablation of ventricular tachycardia in 2021 |
| title_full_unstemmed | Ablation of ventricular tachycardia in 2021 |
| title_short | Ablation of ventricular tachycardia in 2021 |
| title_sort | ablation of ventricular tachycardia in 2021 |
| topic | Articles |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876297/ https://www.ncbi.nlm.nih.gov/pubmed/35233211 http://dx.doi.org/10.1093/eurheartj/suab082 |
| work_keys_str_mv | AT bianchistefano ablationofventriculartachycardiain2021 AT cautifilippomaria ablationofventriculartachycardiain2021 |